Willow Biosciences (WLLW) Competitors C$0.01 +0.01 (+100.00%) As of 04/4/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock WLLW vs. LBL, VPH, EVE, DN, ASP, RTI, ENTG, NU, AQS, and VIVShould you be buying Willow Biosciences stock or one of its competitors? The main competitors of Willow Biosciences include Lattice Biologics (LBL), Valeo Pharma (VPH), Eve & Co Incorporated (EVE), Delta 9 Cannabis (DN), Acerus Pharmaceuticals (ASP), Radient Technologies (RTI), Entourage Health (ENTG), NeutriSci International (NU), Aequus Pharmaceuticals (AQS), and Avivagen (VIV). These companies are all part of the "drug manufacturers - specialty & generic" industry. Willow Biosciences vs. Lattice Biologics Valeo Pharma Eve & Co Incorporated Delta 9 Cannabis Acerus Pharmaceuticals Radient Technologies Entourage Health NeutriSci International Aequus Pharmaceuticals Avivagen Willow Biosciences (TSE:WLLW) and Lattice Biologics (CVE:LBL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk. Does the media prefer WLLW or LBL? In the previous week, Willow Biosciences' average media sentiment score of 0.00 equaled Lattice Biologics'average media sentiment score. Company Overall Sentiment Willow Biosciences Neutral Lattice Biologics Neutral Does the MarketBeat Community believe in WLLW or LBL? Lattice Biologics received 53 more outperform votes than Willow Biosciences when rated by MarketBeat users. However, 82.35% of users gave Willow Biosciences an outperform vote while only 69.79% of users gave Lattice Biologics an outperform vote. CompanyUnderperformOutperformWillow BiosciencesOutperform Votes1482.35% Underperform Votes317.65%Lattice BiologicsOutperform Votes6769.79% Underperform Votes2930.21% Which has stronger valuation and earnings, WLLW or LBL? Lattice Biologics has lower revenue, but higher earnings than Willow Biosciences. Lattice Biologics is trading at a lower price-to-earnings ratio than Willow Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWillow BiosciencesC$2.94M0.49-C$7.92M-C$0.05-0.18Lattice BiologicsC$1.56M3.29-C$1.15M-C$0.01-4.44 Is WLLW or LBL more profitable? Lattice Biologics has a net margin of 0.00% compared to Willow Biosciences' net margin of -268.91%. Lattice Biologics' return on equity of 0.00% beat Willow Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Willow Biosciences-268.91% -602.73% -74.79% Lattice Biologics N/A N/A N/A Do institutionals and insiders hold more shares of WLLW or LBL? 0.1% of Willow Biosciences shares are held by institutional investors. 24.3% of Willow Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryLattice Biologics beats Willow Biosciences on 7 of the 12 factors compared between the two stocks. Remove Ads Get Willow Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WLLW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WLLW vs. The Competition Export to ExcelMetricWillow BiosciencesDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$1.45MC$2.18BC$5.25BC$5.30BDividend Yield7.35%2.92%4.89%6.44%P/E Ratio-0.184.2321.1929.31Price / Sales0.49513.86356.80518.34Price / Cash0.8310.2538.1883.21Price / Book7.246.236.243.29Net Income-C$7.92MC$20.70BC$3.20BC$300.28M7 Day PerformanceN/A-3.76%-8.30%-7.18%1 Month PerformanceN/A-5.93%-4.70%-6.59%1 Year PerformanceN/A82.01%2.67%4.28% Willow Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WLLWWillow BiosciencesN/AC$0.01+100.0%N/A-89.5%C$1.45MC$2.94M-0.1819Gap UpLBLLattice BiologicsN/AC$0.04flatN/A+0.0%C$5.13MC$1.56M-4.44N/AVPHValeo PharmaN/AN/AN/AN/AC$4.44MC$53.38M-0.12100EVEEve & Co IncorporatedN/AC$0.10-4.8%N/A+0.0%C$3.68MC$6.36M-0.494Gap DownDNDelta 9 CannabisN/AN/AN/AN/AC$3.02MC$70.65M-0.10200News CoverageASPAcerus PharmaceuticalsN/AN/AN/AN/AC$2.78MC$3.04M-0.0814RTIRadient TechnologiesN/AC$0.01flatN/A+0.0%C$2.70MC$3.15M-0.25500High Trading VolumeENTGEntourage HealthN/AC$0.01-50.0%N/A-66.7%C$1.54MC$41.46M-0.0410,000Gap DownNUNeutriSci InternationalN/AC$0.01-50.0%N/A+0.0%C$892,000.00C$432,451.00-2.50147,000Gap DownAQSAequus PharmaceuticalsN/AC$0.01-50.0%N/A-60.0%C$663,000.00C$1.17M-0.5012Gap DownVIVAvivagenN/AC$0.01flatN/A+0.0%C$388,000.00C$403,780.00-0.0834,000 Remove Ads Related Companies and Tools Related Companies LBL Alternatives VPH Alternatives EVE Alternatives DN Alternatives ASP Alternatives RTI Alternatives ENTG Alternatives NU Alternatives AQS Alternatives VIV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:WLLW) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Willow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WLLW Stock Free WLLW Stock Alerts